Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Apr 14, 2012; 18(14): 1565-1572
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1565
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1565
Adjuvant and neoadjuvant treatment in pancreatic cancer
Marta Herreros-Villanueva, Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Medicine, Mayo Clinic, Rochester, MN 55905, United States
Elizabeth Hijona, Angel Cosme, Luis Bujanda, Department of Gastroenterology, Centro de Investigacion Biomédica en Red en Enfermedades Hepáticas y Digestivas, University of the Basque Country, Donostia Hospital, 20014 San Sebastian, Spain
Author contributions: All the authors contributed equally to this work.
Supported by Instituto Salud Carlos III
Correspondence to: Luis Bujanda, MD, PhD, Professor, Department of Gastroenterology, Centro de Investigacion Biomédica en Red en Enfermedades Hepáticas y Digestivas, University of the Basque Country, Donostia Hospital, Paseo Dr. Beguiristain S/N, 20014 San Sebastian, Spain. luis.bujanda@osakidetza.net
Telephone: +34-94-3007173 Fax: +34-94-300706
Received: August 28, 2011
Revised: October 23, 2011
Accepted: January 22, 2012
Published online: April 14, 2012
Revised: October 23, 2011
Accepted: January 22, 2012
Published online: April 14, 2012
Core Tip